These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10433626)

  • 1. Re: Lest we abandon digital rectal examination as a screening test for prostate cancer.
    Schröder FH
    J Natl Cancer Inst; 1999 Aug; 91(15):1331-2. PubMed ID: 10433626
    [No Abstract]   [Full Text] [Related]  

  • 2. Lest we abandon digital rectal examination as a screening test for prostate cancer.
    Basler JW; Thompson IM
    J Natl Cancer Inst; 1998 Dec; 90(23):1761-3. PubMed ID: 9839511
    [No Abstract]   [Full Text] [Related]  

  • 3. Update on urology--prostate cancer. Screening for prostate cancer: an European view.
    de Silva FC
    Eur J Surg Oncol; 1996 Apr; 22(2):189-91, 196. PubMed ID: 8608840
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
    Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R
    J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DRE-PSA data revisited: PSA sampling should precede DREs.
    Douville P; Cembrowski G
    Arch Intern Med; 1996 Jun; 156(12):1352-3. PubMed ID: 8651846
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An analysis of preliminary results in screening for prostatic cancer].
    Matveev BP; Bukharkin BV; Komarova LE; Kadagidze ZG; Sholokhov VN; Sokolov AV; Smirnov AV; Cheban NL; Perederiĭ NV; Lepédatu PI
    Urol Nefrol (Mosk); 1998; (2):30-4. PubMed ID: 9577701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality. A case-control study.
    Walsh PC
    J Urol; 2005 Nov; 174(5):1824-5. PubMed ID: 16217296
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
    Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kiwi conundrum: Screening for prostate cancer.
    Kuska B
    J Natl Cancer Inst; 1997 Jul; 89(14):1000. PubMed ID: 9244811
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate-specific antigen coordinated with digital rectal examination and transrectal ultrasonography in the detection of prostate cancer.
    Cooner WH
    World J Urol; 1993; 11(4):214-7. PubMed ID: 7508786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Prostate-specific antigen: a misused and maligned prostate cancer biomarker.
    Hamilton RJ; Platz EA; Freedland SJ
    J Natl Cancer Inst; 2009 Apr; 101(8):611-2. PubMed ID: 19351913
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for prostate cancer. The challenge of promoting informed decision making in the absence of definitive evidence of effectiveness.
    Burack RC; Wood DP
    Med Clin North Am; 1999 Nov; 83(6):1423-42, vi. PubMed ID: 10584601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for prostate cancer: recommendations and rationale.
    Berg AO;
    Am J Nurs; 2003 Mar; 103(3):107-10; discussion 111. PubMed ID: 12626949
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate-specific antigen: the new early detection test for prostate cancer.
    Greco KE; Blank B
    Nurse Pract; 1993 May; 18(5):30-8. PubMed ID: 7689192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should routine screening for prostate-specific antigen be recommended?
    Oottamasathien S; Crawford ED
    Arch Intern Med; 2003 Mar; 163(6):661-2; discussion 666. PubMed ID: 12639195
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate specific antigen and screening for early prostate cancer.
    Davidson P
    N Z Med J; 2001 Apr; 114(1129):150. PubMed ID: 11400919
    [No Abstract]   [Full Text] [Related]  

  • 18. How to use prostate-specific antigen in the early detection or screening for prostatic carcinoma.
    Brawer MK
    CA Cancer J Clin; 1995; 45(3):148-64. PubMed ID: 7538043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for prostate cancer: enthusiasm.
    Catalona WJ
    Urology; 1993 Aug; 42(2):113-5. PubMed ID: 7690167
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for prostatic carcinoma.
    Hinman F
    J Urol; 1991 Jan; 145(1):126-9; discussion 129-30. PubMed ID: 1701495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.